MLchartDataset catalogue

Sylatron

Term · Oncology and biomedicine · MLC-T-ONC-008434

A drug that is no longer available in the United States that contains the active ingredient peginterferon alfa-2b and was used to prevent melanoma from coming back after it has been removed by surgery. Sylatron is a type of cytokine and a type of immunomodulating agent.

Table 1. Record
IdentifierMLC-T-ONC-008434
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-008434",
  "term": "Sylatron",
  "field": "Oncology and biomedicine",
  "definition": "A drug that is no longer available in the United States that contains the active ingredient peginterferon alfa-2b and was used to prevent melanoma from coming back after it has been removed by surgery. Sylatron is a type of cytokine and a type of immunomodulating agent.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sylatron/"
}

Record 15,859 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.